QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

NEW YORK, March 20 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

    Autoimmune-Inflammation Index (HHA)
    Drop
    GW Pharmaceuticals, Inc (LSE:GWP.L)
    Human Genome Sciences (NASDAQ:HGSI)
    Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)
    Add
    Fornix Biosciences N.V. 
    Meda AB (SHSE1: MEDA A)
    Mitsubishi Tanabe Pharma Corporation 

    Cancer Index (HHK)
    Drop
    Shire PLC (NASDAQ:SHPGY)
    Add
    Ark Therapeutics Group Plc (LSE:AKT.L)

    Cardio Devices Index (HHE)
    Drop
    Biosphere Medical, Inc. (NASDAQ:BSMD)
    Add
    Zoll Medical Corp. (NASDAQ:ZOLL)

    Cardiology Index (HRD)
    Drop
    Encysive Pharmaceuticals, Inc. (NASDAQ:ENCY)
    Human Genome Sciences, Inc (NASDAQ:HGSI)
    Vical, Inc. (NASDAQ:VICL)
    Add
    Mitsubishi Tanabe Pharma Corporation 
    Sangamo BioSciences Inc. (NASDAQ:SGMO)
    Sciele Pharma, Inc. (NASDAQ:SCRX)

    Composite Index (HHQ)
    Drop
    Advanced Medical Optics, Inc. (NYSE:EYE)
    Align Technology Inc. (NASDAQ:ALGN)
    Array Biopharma Inc. (NASDAQ:ARRY)
    ArthroCare Corp. (NASDAQ:ARTC)
    Endo Pharmaceuticals Hldgs. (NASDAQ:ENDP)
    Fresenius Medical Care AG (XETRA: FME.DE)
    GEDEON RICHTER RT (XETRA: R1G1.DE)
    GENMAB A/S (Copenhagen: GEN.CO)
    H LUNDBECK A/S (Copenhagen: LUN.CO)
    Human Genome Sciences (NASDAQ:HGSI)
    Imclone Systems (NASDAQ:IMCL)
    Inverness Medical Innovations (AMEX:IMA)
    Invitrogen Corp. (NASDAQ:IVGN)
    Medarex Inc. (NASDAQ:MEDX)
    Medicis Pharmaceutical (NYSE:MRX)
    Mentor Corp. (NYSE:MNT)
    ONYX Pharmaceuticals Inc. (NASDAQ:ONXX)
    PDL BioPharma, Inc. (NASDAQ:PDLI)
    Pharmion Corp. (NASDAQ:PHRM)
    Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)
    Regeneron Pharmaceuticals (NASDAQ:REGN)
    Respironics Inc. (NASDAQ:RESP)
    Sepracor Inc. (NASDAQ:SEPR)
    Theravance Inc. (NASDAQ:THRX)
    United Therapeutics Corp. (NASDAQ:UTHR)
    Valeant Pharmaceuticals Int'l (NYSE:VRX)
    Vertex Pharmaceuticals (NASDAQ:VRTX)
    Add
    Adolor Corp. (NASDAQ:ADLR)
    ALLOS THERAPEUTICS INC. (NASDAQ:ALTH)
    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
    Alpharma Inc. (NYSE:ALO)
    Altus Pharmaceuticals Inc. (NASDAQ:ALTU)
    AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)
    ANGIOTECH PHARMACEUTICALS (NASDAQ:ANPI)
    Ark Therapeutics (LSE:AKT.L)
    Bavarian Nordic A/S (Copenhagen: BAVA.CO)
    Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD)
    Cardiome Pharma Corp. (NASDAQ:CRME)
    Coventry Health Care Inc. (NYSE:CVH)
    CRUCELL-ADR (NASDAQ:CRXL)
    CUBIST PHARMACEUTICALS INC. (NASDAQ:CBST)
    Discovery Laboratories Inc. (NASDAQ:DSCO)
    Eisai Co. Ltd. 
    Encysive Pharmaceuticals Inc. (NASDAQ:ENCY)
    Enzo Biochem Inc. (NYSE:ENZ)
    ENZON PHARMACEUTICALS INC. (NASDAQ:ENZN)
    Exelixis Inc. (NASDAQ:EXEL)
    Flamel Technologies (NASDAQ:FLML)
    Illumina Inc. (NASDAQ:ILMN)
    Incyte Corporation (NASDAQ:INCY)
    Integra LifeSciences Holdings (NASDAQ:IART)
    Meda AB (Stockholm: MEDAA.ST)
    Mitsubishi Tanabe Pharma 
    Taisho Pharmaceutical Co., Ltd. 

    Dermatology and Wound Index (HRW)
    Drop
    Shire PLC (ADR) (NASDAQ:SHPGY)
    SkyePharma Plc 
    Add
    Standard Chemical & Pharm. Co., Ltd. 
    Taisho Pharmaceutical Co., Ltd. 

    Diagnostics Index (HHD)
    Drop
    CR Bard, Inc. (NYSE:BCR)
    IDEXX Laboratories (NASDAQ:IDXX)
    Add
    Bruker Corporation (NASDAQ:BRKR)
    Halozyme Therapeutic (NASDAQ:HALO)

    Emerging Cancer Index (HHJ)
    Drop
    Adventrx Pharmaceuticals, Inc. (AMEX:ANX)
    Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)
    Add
    Dyanvax Technologies (NASDAQ:DVAX)
    Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

    Enabling Technologies Index (HHV)
    Drop
    Hillenbrand Industries (NYSE:HB)
    Add
    Eurand N.V. (NASDAQ:EURX)

    GI/Gender Index (HHU)
    Drop
    AEterna Zentaris (NASDAQ:AEZS)
    King Pharmaceuticals (NYSE:KG)
    Nastech Pharmaceutical (NASDAQ:NSTK)
    Add
    Columbia Laboratories Inc. (NASDAQ:CBRX)
    Eisai Co. Ltd. 
    Mylan, Inc. (NYSE:MYL)

    Metabolic-Endocrine Disorders Index (HHM)
    Drop
    Depomed Inc. (NASDAQ:DEPO)
    Emisphere Technologies Inc. (NASDAQ:EMIS)
    Flamel Technologies SA ADS (NASDAQ:FLML)
    Hospira Inc. (NYSE:HSP)
    Human Genome Sciences, Inc. (NASDAQ:HGSI)
    Indevus Pharmaceuticals Inc. (NASDAQ:IDEV)
    Ipsen Ltd. 
    Nektar Therapeutics (NASDAQ:NKTR)
    NicOx S.A. 
    OSI Pharmaceuticals Inc. (NASDAQ:OSIP)
    ProStrakan Group Plc (LSE:PSK.L)
    Solvay S.A. (Brussels: SVYSY)
    Add
    Altus Pharmaceuticals Inc. (NASDAQ:ALTU)
    Amicus Therapeutics, Inc. (NASDAQ:FOLD)
    Biodell Inc. (NASDAQ:BIOD)
    CombinatoRx Inc. (NASDAQ:CRXX)
    GW Pharmaceuticals Plc (LSE:GWP.L)
    Incyte Corp. (NASDAQ:INCY)
    Orexigen Therapeutics, Inc. (NASDAQ:OREX)
    Repros Therapeutics Inc. (NASDAQ:RPRX)
    Sirtris Pharmaceuticals, Inc. (NASDAQ:SIRT)
    SuperGen Inc. (NASDAQ:SUPG)
    Transition Therapeutics Inc. (NASDAQ:TTHI)
    XOMA Ltd. (NASDAQ:XOMA)

    Neuroscience Index (HHN)
    Drop
    Neurochem Inc. (NASDAQ:NRMX)
    Add
    Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD)

    Ophthalmology Index (HHZ)
    Drop
    Insite Vision Inc. (AMEX:ISV)
    Add
    King Pharmaceuticals (NYSE:KG)
    Patient Care Services Index (HHB)
    Drop
    Fresenius Medical Care (XETRA: FME.DE)
    Add
    Coventry Health Care Inc. (NYSE:CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at www.qedinternational.com

Source: QED International Associates Inc.,

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here